HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT04469959

Dopaminergic Dysfunction in Late-Life Depression

It focuses on depression and currently lists study information in the United States.

Depression, Cognitive Decline, ...DrugOver 60 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 60 years.

Listed locations
Pittsburgh, United States · Nashville, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: February 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
79
Sponsor
Vanderbilt University Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 60 Years
Official registry ID
NCT04469959
Official title
Dopaminergic Dysfunction in Late-Life Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh · Nashville

Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Vanderbilt University Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including L-Dopa and Placebo.

Who was this study for?

Listed age limits: from 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.